4.8 Article

A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)

期刊

BMC MEDICINE
卷 15, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s12916-017-0791-y

关键词

Depression; Major depressive disorder; Diet; Nutrition; Randomised controlled trial; Dietetics

资金

  1. National Health and Medical Research Council of Australia (NHMRC) [1021347]
  2. Woolworths Limited
  3. Meat and Livestock Australia
  4. Brain and Behaviour Research Institute
  5. National Health and Medical Research Council (NHMRC)
  6. Australian Rotary Health
  7. Geelong Medical Research Foundation
  8. Ian Potter Foundation
  9. Eli Lilly
  10. University of Melbourne
  11. NHMRC Career Development Fellowship [1108125]
  12. NHMRC ECR Fellowship [1052865]
  13. NHMRC
  14. Deakin University
  15. La Trobe University
  16. Meat and Livestock Board
  17. Australian Society for Enteral and Parenteral Nutrition
  18. Harokopio University in Athens
  19. Commonwealth Department of Education, Employment and Workplace relations
  20. Diabetes Australia
  21. SWISSE Wellness P/L
  22. NHMRC Early Career Development Fellowship [1035887]
  23. Cancer Council
  24. Mental Illness Research Fund
  25. Medibank Private Health Research Fund
  26. Macquarie University
  27. Beyond Blue
  28. Janssen Cilag
  29. Roche
  30. Allergen
  31. Bristol-Myers Squibb
  32. Pfizer
  33. Lundbeck
  34. Astra Zeneca
  35. Hospira
  36. Brain and Behaviour Foundation
  37. Marion and EH Flack Trust
  38. Simons Autism Foundation
  39. Stanley Medical Research Institute
  40. Australasian Society for Bipolar and Depressive Disorders
  41. Servier
  42. BioMedica Nutracuticals
  43. NutritionCare
  44. Bioceuticals
  45. NIH
  46. Cooperative Research Centre
  47. Cancer Council of Victoria
  48. Stanley Medical Research Foundation
  49. MBF
  50. Rotary Health
  51. Bristol Myers Squibb
  52. Glaxo SmithKline
  53. Organon
  54. Novartis
  55. Mayne Pharma
  56. Woolworths
  57. NHMRC Senior Principal Research Fellowship [1059660]

向作者/读者索取更多资源

Background: The possible therapeutic impact of dietary changes on existing mental illness is largely unknown. Using a randomised controlled trial design, we aimed to investigate the efficacy of a dietary improvement program for the treatment of major depressive episodes. Methods: 'SMILES' was a 12-week, parallel-group, single blind, randomised controlled trial of an adjunctive dietary intervention in the treatment of moderate to severe depression. The intervention consisted of seven individual nutritional consulting sessions delivered by a clinical dietician. The control condition comprised a social support protocol to the same visit schedule and length. Depression symptomatology was the primary endpoint, assessed using the Montgomery-angstrom sberg Depression Rating Scale (MADRS) at 12 weeks. Secondary outcomes included remission and change of symptoms, mood and anxiety. Analyses utilised a likelihood-based mixed-effects model repeated measures (MMRM) approach. The robustness of estimates was investigated through sensitivity analyses. Results: We assessed 166 individuals for eligibility, of whom 67 were enrolled (diet intervention, n = 33; control, n = 34). Of these, 55 were utilising some form of therapy: 21 were using psychotherapy and pharmacotherapy combined; 9 were using exclusively psychotherapy; and 25 were using only pharmacotherapy. There were 31 in the diet support group and 25 in the social support control group who had complete data at 12 weeks. The dietary support group demonstrated significantly greater improvement between baseline and 12 weeks on the MADRS than the social support control group, t(60.7) = 4.38, p < 0.001, Cohen's d = -1.16. Remission, defined as a MADRS score < 10, was achieved for 32.3% (n = 10) and 8.0% (n = 2) of the intervention and control groups, respectively (chi(2) (1) = 4.84, p = 0.028); number needed to treat (NNT) based on remission scores was 4.1 (95% CI of NNT 2.3-27.8). A sensitivity analysis, testing departures from the missing at random (MAR) assumption for dropouts, indicated that the impact of the intervention was robust to violations of MAR assumptions. Conclusions: These results indicate that dietary improvement may provide an efficacious and accessible treatment strategy for the management of this highly prevalent mental disorder, the benefits of which could extend to the management of common co-morbidities.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据